Skip to main content
July 6, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
IKEMA
Multiple Myeloma Treatment
Sarclisa (isatuximab) – Anti CD38 Targeted Therapy for Myeloma
By Dr. C.H. Weaver M.D.
May 16, 2022
CLOSE
CLOSE
CLOSE
CLOSE